BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Recademy - ECPv6.17.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Recademy
X-ORIGINAL-URL:https://recademy.com
X-WR-CALDESC:Events for Recademy
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260421T130000
DTEND;TZID=America/New_York:20260421T140000
DTSTAMP:20260608T195319Z
CREATED:20260309T144648Z
LAST-MODIFIED:20260608T195319Z
UID:5552-1776776400-1776780000@recademy.com
SUMMARY:Recognizing & Treating Opioid Use Disorder (OUD) As A Chronic Brain Disease: The Latest Research\, Treatment Frameworks & Care Pathways
DESCRIPTION:In this RECADEMY fireside conversation\, we’ll explore how advances in neuroscience are reshaping clinical thinking about opioid use disorder\, and what this means for patient engagement\, treatment duration\, and system design across inpatient and outpatient care settings. \n\n\n\nRecognizing opioid use disorder as a chronic brain disease can have important implications for how care is delivered\, how relapses are interpreted\, and how long-term recovery can be supported. Dr. Bilal and Dr. Buttlaire will walk us thru the latest neuroscience research explaining the chronic nature of opioid use disorder. \n\n\n\n\n\n\n\n\nWhat You’ll Learn:\n\n\n\n\n\n\n\n\nThe importance of seeing relapse as a clinical signal rather than treatment failure\n\n\n\nHow the brain disease model changes expectations for treatment duration and long-term engagement\n\n\n\nWhat the chronic disease framework means for inpatient stabilization\, discharge planning\, and continuity of care\n\n\n\nHow health systems can reduce stigma and redesign care pathways to better support sustained recovery\n\n\n\n\n\n\n\n\nSpeakers:\n\n\n\n\n\n	\n			\n		\n						\n							\n						\n						\n\n\n\n\n\n\nLouai Bilal\, MD\, MSc\n\n\n\n\n\n\n\nMedical Director\, Kaiser Fremont Medical Psychiatric Unit \n\n\n\n\n\n\nBiography\n\n\n\n\n\n\n\nDr. Bilal is currently the Medical Director of the Kaiser Fremont MPU\, Assistant Chief of Hospital Staff in KP Fremont\, and interim Medical Director at Telecare Heritage Hospital. He has been an inpatient psychiatrist throughout his career and has consulted on medical floors and emergency rooms. In addition to clinical care\, he has been heavily involved in postgraduate education\, acting as site director for many medical student clerkships and later for Kaiser’s own psychiatric residencies in Oakland and San Jose. He is the Program Director of Psychiatric Education at the GSAA and has helped lead the efforts toward internalizing ECT service in KP SCL\, expanding the use of ECT in Fremont to include inpatient ECT and court ordered treatments.  \n\n\n\n\n\n\n \n\n		\n	\n		\n	\n	\n		\n		\n			Louai Bilal\n			\n				Medical Director\, 	\n				Kaiser Fremont Medical Center 	\n			\n										\n					Read More				\n					\n	\n\n\n\n\n\n\n	\n			\n		\n						\n							\n						\n						\n\n\n\n\n\n\n\n\n\n\n\nStuart Buttlaire \n\n\n\n\n\n\n\nVice President Of Clinical Excellence & Leadership \n\n\n\n\n\n\n\ninfo@openminds.com \n\n\n\n717-334-1329 \n\n\n\nGettysburg\, Pennsylvania \n\n\n\n\n\n\n\n\n\nExpertise\n\n\n\n\nStrategic planning for mental health and substance use delivery systems \n\n\n\nIntegrated behavioral health system design \n\n\n\nBehavioral health financing and policy reform and state and federal legislative and regulatory strategy \n\n\n\nMeasurement-based care and clinical performance management \n\n\n\nBehavioral health policy authorship and thought leadership \n\n\n\n\nHighlights\n\n\n\n\nRegional Director of Behavioral Health and Addiction Medicine\, Kaiser Permanente \n\n\n\nBoard President\, Institute for Behavioral Health Improvement \n\n\n\nBoard Member\, NAMI California \n\n\n\nAdvisor on Medicaid and Medicare behavioral health programs \n\n\n\n\n\n\n\n\nBiography\n\n\n\n\n\n\n\nStuart Buttlaire brings over 35 years of executive\, clinical\, and policy experience to OPEN MINDS. Dr. Buttlaire has experience in both the public and private sectors of healthcare providing leadership and direction in healthcare delivery. His career has focused on advancing integrated behavioral health and addiction medicine through strategic innovation\, system redesign\, quality improvement\, and sustainable policy reform.Previously\, Dr. Buttlaire was the Regional Director of Behavioral Health and Addiction Medicine for Kaiser Permanente. In this role\, Dr. oversaw a $200 million portfolio serving 4.6 million members across 23 emergency departments and 33 medical centers. He led development and operations across inpatient\, ambulatory\, emergency\, call center\, and contracted community services\, supporting more than 2\,500 mental health and substance use disorder providers. His leadership resulted in significant system transformation grounded in person-centered\, measurement-based\, and integrated care models. Dr. Buttlaire was also the lead Mental Health Representative for State Program Initiatives\, including Medicaid (Medi-Cal) and Medicare. He pioneered the design and implementation of two psychiatric inpatient units\, including a nationally recognized medical/psychiatric unit for individuals with complex co-morbidities. Additional innovations include integrated urgent services for youth and adults\, intensive outpatient programs\, multi-family group treatments for severe psychiatric conditions\, and a mobile app for eating disorders that earned Kaiser’s Innovation Award.Dr. Buttlaire is a widely respected advisor on behavioral health policy\, legislation\, and regulatory strategy. He has worked closely with state and federal agencies on issues of parity enforcement\, financing reform\, Medicaid redesign\, and systems integration. He currently serves as Board President of the Institute for Behavioral Health Improvement\, is a Board Member of NAMI California\, and sits on the California Hospital Association Behavioral Health Advisory Board. He previously chaired the Behavioral Health Section of the American Hospital Association and was appointed to the AHA Regional Policy Board for the Western U.S.As a frequent speaker and author\, Dr. Buttlaire has published articles and research papers on behavioral health integration\, suicide prevention\, financing\, and policy reform. His work continues to shape strategic direction for public and private behavioral health systems across the country.Dr. Buttlaire holds a Ph.D. in Clinical Psychology from the California Institute of Integral Studies\, an MBA with a concentration in Health Care Management and Finance from UC Irvine’s Paul Merage School of Business\, a Master’s in Counseling Psychology from Humboldt State\, and a B.A. in Psychology and Political Science from the University of Colorado. \n\n\n\n\n		\n	\n		\n	\n	\n		\n		\n			Stuart Buttlaire\n			\n				Vice President Of Clinical Excellence & Leadership\, 	\n				OPEN MINDS 	\n			\n										\n					Read More				\n					\n	\n\n\n\n\n\n\n \n\n\n\n\n\n\n	\n		\n							\n					\n				\n						\n				Tuesday\, November 3rd \n				1:00 pm ET to 2:00 pm ET \n			\n		\n				\n							\n					\n				\n						\n				Online Webinar \n																	Link Available for Attendees \n																			\n		\n	\n\n\n\n\n\n\n\nEvent Details: Everything inside this box will not show on the front end but will be used by the event template
URL:https://recademy.com/event/recognizing-and-treating-opioid-use-disorder-oud-as-a-chronic-brain-disease-the-latest-research-treatment-frameworks-and-care-pathways/
ATTACH;FMTTYPE=image/jpeg:https://recademy.com/wp-content/uploads/2026/03/Web4.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260331T110000
DTEND;TZID=America/New_York:20260331T120000
DTSTAMP:20260608T195324Z
CREATED:20260305T153150Z
LAST-MODIFIED:20260608T195324Z
UID:5426-1774954800-1774958400@recademy.com
SUMMARY:Treating Fentanyl & High-Potency Synthetic Opioid (HPSO) Use Disorder: Evidence-Based MOUD Protocols\, Induction Strategies\, & Harm Reduction Approaches in Real-World Care Settings
DESCRIPTION:Recent CDC national data shows that while total drug overdose deaths have declined from their peak\, synthetic opioids remain the dominant driver of opioid-related mortality. In the most recent finalized CDC national data\, synthetic opioids were involved in roughly 70% of all overdose deaths and most opioid-related deaths. \n\n\n\nThe efficacy of methadone and buprenorphine is well established. CDC national data and NIDA continue to affirm that medications for opioid use disorder are associated with significant reductions in both overdose and all-cause mortality\, and that retention in treatment is strongly associated with survival. In fact\, federal guidance often summarizes the impact this way: treatment with methadone or buprenorphine can reduce the risk of death by at least half.   \n\n\n\nThe question is no longer whether MOUD works.  The more pressing question is whether our clinical protocols\, operational workflows\, workforce competencies\, and reimbursement models have kept pace with the fentanyl era.  \n\n\n\nFentanyl is not only a clinical challenge.  It is a system design challenge.  That is what we will explore in this webinar. \n\n\n\n\n\n\n\n\nKey Topics Include:\n\n\n\n\n\n\n\n\nHow should induction strategies evolve in high-fentanyl exposure settings? \n\n\n\nWhen should methadone be prioritized for patients with very high tolerance? \n\n\n\nHow should low-dose or flexible induction strategies be implemented safely and consistently? \n\n\n\nHow do we embed harm reduction into core system infrastructure rather than treating it as an adjunct? \n\n\n\nHow do we manage fentanyl combined with stimulants and other substances? \n\n\n\nAnd how do we scale these approaches across large public systems under workforce shortages and financial pressure?\n\n\n\n\n\n\n\n\nSpeakers\n\n\n\n\n\n	\n			\n		\n						\n							\n						\n						\n\n\n\n\n\n\nBrian Hurley\, MD\, MBA\, FAPA\, DFSAM\n\n\n\n\n\n\n\nMedical Director\, Los Angeles County Department of Public Health’s Bureau of Substance Abuse Prevention and Control  \n\n\n\n\n\n\nBiography\n\n\n\n\n\n\n\nBrian Hurley\, MD\, MBA\, FAPA\, DFASAM is an addiction physician and the Medical Director of the Bureau of Substance Abuse Prevention and Control for the Los Angeles County Department of Public Health. Brian currently serves as Immediate Past President of the American Society of Addiction Medicine. He has served on a variety of committees and councils at ASAM including originating ASAM’s Motivational Interviewing course and co-authoring the ASAM and AAAP National Practice Guideline on the Treatment of Stimulant Use Disorder.   \n\n\n\nDr. Hurley has led and facilitated projects funded through competitive grant awards from the U.S. Substance Abuse and Mental Health Services Administration\, the U.S. Centers for Disease Control and Prevention\, and the California Department of Health Care Services’ Opioid Response Programming in partnership with The Center at Sierra Health Foundation. These projects support harm reduction services and increase the availability of addiction medications in public sector programs across Los Angeles County.   \n\n\n\nBrian is a member of the Motivational Interviewing Network of Trainers. He completed the Robert Wood Johnson Foundation Clinical Scholars Program at the University of California\, Los Angeles (UCLA) and is an alumnus of the Massachusetts General Hospital and McLean Hospital Psychiatry Residency Training Program and the New York University Addiction Psychiatry Fellowship. Additionally\, he has served various roles for the Massachusetts Society of Addiction Medicine\, New York Society of Addiction Medicine\, and California Society of Addiction Medicine.  \n\n\n\n\n\n\n \n\n		\n	\n		\n	\n	\n		\n		\n			Brian Hurley MD\, MBA\, FAPA\, DFSAM\n			\n				Medical Director\, 	\n				Los Angeles County Department of Public Health’s Bureau of Substance Abuse Prevention and Control  	\n			\n										\n					Read More				\n					\n	\n\n\n\n\n\n\n	\n			\n		\n						\n							\n						\n						\n\n\n\n\n\n\n\n\n\n\n\nStuart Buttlaire \n\n\n\n\n\n\n\nVice President Of Clinical Excellence & Leadership \n\n\n\n\n\n\n\ninfo@openminds.com \n\n\n\n717-334-1329 \n\n\n\nGettysburg\, Pennsylvania \n\n\n\n\n\n\n\n\n\nExpertise\n\n\n\n\nStrategic planning for mental health and substance use delivery systems \n\n\n\nIntegrated behavioral health system design \n\n\n\nBehavioral health financing and policy reform and state and federal legislative and regulatory strategy \n\n\n\nMeasurement-based care and clinical performance management \n\n\n\nBehavioral health policy authorship and thought leadership \n\n\n\n\nHighlights\n\n\n\n\nRegional Director of Behavioral Health and Addiction Medicine\, Kaiser Permanente \n\n\n\nBoard President\, Institute for Behavioral Health Improvement \n\n\n\nBoard Member\, NAMI California \n\n\n\nAdvisor on Medicaid and Medicare behavioral health programs \n\n\n\n\n\n\n\n\nBiography\n\n\n\n\n\n\n\nStuart Buttlaire brings over 35 years of executive\, clinical\, and policy experience to OPEN MINDS. Dr. Buttlaire has experience in both the public and private sectors of healthcare providing leadership and direction in healthcare delivery. His career has focused on advancing integrated behavioral health and addiction medicine through strategic innovation\, system redesign\, quality improvement\, and sustainable policy reform.Previously\, Dr. Buttlaire was the Regional Director of Behavioral Health and Addiction Medicine for Kaiser Permanente. In this role\, Dr. oversaw a $200 million portfolio serving 4.6 million members across 23 emergency departments and 33 medical centers. He led development and operations across inpatient\, ambulatory\, emergency\, call center\, and contracted community services\, supporting more than 2\,500 mental health and substance use disorder providers. His leadership resulted in significant system transformation grounded in person-centered\, measurement-based\, and integrated care models. Dr. Buttlaire was also the lead Mental Health Representative for State Program Initiatives\, including Medicaid (Medi-Cal) and Medicare. He pioneered the design and implementation of two psychiatric inpatient units\, including a nationally recognized medical/psychiatric unit for individuals with complex co-morbidities. Additional innovations include integrated urgent services for youth and adults\, intensive outpatient programs\, multi-family group treatments for severe psychiatric conditions\, and a mobile app for eating disorders that earned Kaiser’s Innovation Award.Dr. Buttlaire is a widely respected advisor on behavioral health policy\, legislation\, and regulatory strategy. He has worked closely with state and federal agencies on issues of parity enforcement\, financing reform\, Medicaid redesign\, and systems integration. He currently serves as Board President of the Institute for Behavioral Health Improvement\, is a Board Member of NAMI California\, and sits on the California Hospital Association Behavioral Health Advisory Board. He previously chaired the Behavioral Health Section of the American Hospital Association and was appointed to the AHA Regional Policy Board for the Western U.S.As a frequent speaker and author\, Dr. Buttlaire has published articles and research papers on behavioral health integration\, suicide prevention\, financing\, and policy reform. His work continues to shape strategic direction for public and private behavioral health systems across the country.Dr. Buttlaire holds a Ph.D. in Clinical Psychology from the California Institute of Integral Studies\, an MBA with a concentration in Health Care Management and Finance from UC Irvine’s Paul Merage School of Business\, a Master’s in Counseling Psychology from Humboldt State\, and a B.A. in Psychology and Political Science from the University of Colorado. \n\n\n\n\n		\n	\n		\n	\n	\n		\n		\n			Stuart Buttlaire Ph.D\n			\n				Vice President Of Clinical Excellence & Leadership\, 	\n				OPEN MINDS 	\n			\n										\n					Read More				\n					\n	\n\n\n\n\n\n\n \n\n\n\n\n\n\n	\n		\n							\n					\n				\n						\n				Tuesday\, November 3rd \n				1:00 pm ET to 2:00 pm ET \n			\n		\n				\n							\n					\n				\n						\n				Online Webinar \n																	Link Available for Attendees \n																			\n		\n	\n\n\n\n\n\n\n\nEvent Details: Everything inside this box will not show on the front end but will be used by the event template
URL:https://recademy.com/event/treating-fentanyl-high-potency-synthetic-opioid-hpso-use-disorder-evidence-based-moud-protocols-induction-strategies-harm-reduction-approaches-in-real-world-care-settings/
ATTACH;FMTTYPE=image/jpeg:https://recademy.com/wp-content/uploads/2026/03/Web3PR.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260319T110000
DTEND;TZID=America/New_York:20260319T120000
DTSTAMP:20260608T195337Z
CREATED:20260213T154153Z
LAST-MODIFIED:20260608T195337Z
UID:5195-1773918000-1773921600@recademy.com
SUMMARY:What’s Working in OUD Treatment & System Transformation: The ROI of MOUD in Health Systems\, Payers & Communities
DESCRIPTION:What does it take to deliver effective opioid use disorder treatment in today’s healthcare environment? \n\n\n\nHealth systems and provider organizations are rethinking how care is delivered – aligning clinical practice\, workflow design\, and medication strategies to strengthen patient engagement\, improve continuity of care\, and drive better system performance.   \n\n\n\nIn this session\, we’ll examine what’s working in real-world provider settings and explore the business case for MOUD; from improving patient stability and retention\, and strengthening operational efficiency and total cost of care. \n\n\n\n\n\n\n\n\nWhat You’ll Learn:\n\n\n\n\n\n\n\n\nIdentify system-level care models that improve OUD outcomes\, including ED pathways\, CCBHC approaches\, jail MOUD programs\, and rapid-access clinics \n\n\n\nDescribe the clinical and operational advantages of MOUD in stabilizing patients and reducing early dropout \n\n\n\nEvaluate the financial ROI of MOUD for health systems\, payers\, and community agencies using real-world scenarios \n\n\n\nAnalyze transition points that drive the highest overdose risk and apply workflows that close these gaps \n\n\n\nApply system redesign strategies to build sustainable\, high-performing MOUD programs \n\n\n\n\n\n\n\n\nSpeakers\n\n\n\n\n\n	\n			\n		\n						\n							\n						\n						\n\n\n\n\n\n\nCharles C. Whitehall\, MD\n\n\n\nKaiser Permanente Napa-Solano \n\n\n\n\n\n\nBiography\n\n\n\n\n\n\n\nCharles Whitehall MS\, MD currently serves as the Chief of Addiction Medicine and Recovery Services (AMRS) for Kaiser Napa-Solano. He is board-certified in both Family Medicine and Addiction Medicine. Before focusing his career on addiction medicine in 2014\, Dr. Whitehill practiced family medicine in diverse clinical settings beginning in 2002. His approach to care emphasizes compassionate\, accessible\, and evidence-based addiction treatment. Outside of work\, he enjoys training for triathlons\, sailing with family\, or playing the Great Highland bagpipes.  \n\n\n\n\n\n\n \n\n		\n	\n		\n	\n	\n		\n		\n			Charles C. Whitehall MD\n			\n				Chief of Addiction Medicine and Recovery Services\, 	\n				Kaiser Permanente Napa-Solano 	\n			\n										\n					Read More				\n					\n	\n\n\n\n\n\n\n	\n			\n		\n						\n							\n						\n						\n\n\n\n\n\n\n\n\n\n\n\nStuart Buttlaire \n\n\n\n\n\n\n\nVice President Of Clinical Excellence & Leadership \n\n\n\n\n\n\n\ninfo@openminds.com \n\n\n\n717-334-1329 \n\n\n\nGettysburg\, Pennsylvania \n\n\n\n\n\n\n\n\n\nExpertise\n\n\n\n\nStrategic planning for mental health and substance use delivery systems \n\n\n\nIntegrated behavioral health system design \n\n\n\nBehavioral health financing and policy reform and state and federal legislative and regulatory strategy \n\n\n\nMeasurement-based care and clinical performance management \n\n\n\nBehavioral health policy authorship and thought leadership \n\n\n\n\nHighlights\n\n\n\n\nRegional Director of Behavioral Health and Addiction Medicine\, Kaiser Permanente \n\n\n\nBoard President\, Institute for Behavioral Health Improvement \n\n\n\nBoard Member\, NAMI California \n\n\n\nAdvisor on Medicaid and Medicare behavioral health programs \n\n\n\n\n\n\n\n\nBiography\n\n\n\n\n\n\n\nStuart Buttlaire brings over 35 years of executive\, clinical\, and policy experience to OPEN MINDS. Dr. Buttlaire has experience in both the public and private sectors of healthcare providing leadership and direction in healthcare delivery. His career has focused on advancing integrated behavioral health and addiction medicine through strategic innovation\, system redesign\, quality improvement\, and sustainable policy reform.Previously\, Dr. Buttlaire was the Regional Director of Behavioral Health and Addiction Medicine for Kaiser Permanente. In this role\, Dr. oversaw a $200 million portfolio serving 4.6 million members across 23 emergency departments and 33 medical centers. He led development and operations across inpatient\, ambulatory\, emergency\, call center\, and contracted community services\, supporting more than 2\,500 mental health and substance use disorder providers. His leadership resulted in significant system transformation grounded in person-centered\, measurement-based\, and integrated care models. Dr. Buttlaire was also the lead Mental Health Representative for State Program Initiatives\, including Medicaid (Medi-Cal) and Medicare. He pioneered the design and implementation of two psychiatric inpatient units\, including a nationally recognized medical/psychiatric unit for individuals with complex co-morbidities. Additional innovations include integrated urgent services for youth and adults\, intensive outpatient programs\, multi-family group treatments for severe psychiatric conditions\, and a mobile app for eating disorders that earned Kaiser’s Innovation Award.Dr. Buttlaire is a widely respected advisor on behavioral health policy\, legislation\, and regulatory strategy. He has worked closely with state and federal agencies on issues of parity enforcement\, financing reform\, Medicaid redesign\, and systems integration. He currently serves as Board President of the Institute for Behavioral Health Improvement\, is a Board Member of NAMI California\, and sits on the California Hospital Association Behavioral Health Advisory Board. He previously chaired the Behavioral Health Section of the American Hospital Association and was appointed to the AHA Regional Policy Board for the Western U.S.As a frequent speaker and author\, Dr. Buttlaire has published articles and research papers on behavioral health integration\, suicide prevention\, financing\, and policy reform. His work continues to shape strategic direction for public and private behavioral health systems across the country.Dr. Buttlaire holds a Ph.D. in Clinical Psychology from the California Institute of Integral Studies\, an MBA with a concentration in Health Care Management and Finance from UC Irvine’s Paul Merage School of Business\, a Master’s in Counseling Psychology from Humboldt State\, and a B.A. in Psychology and Political Science from the University of Colorado. \n\n\n\n\n		\n	\n		\n	\n	\n		\n		\n			Stuart Buttlaire\n			\n				Vice President Of Clinical Excellence & Leadership\, 	\n				OPEN MINDS 	\n			\n										\n					Read More				\n					\n	\n\n\n\n\n\n\n \n\n\n\n\n\n\n	\n		\n							\n					\n				\n						\n				Tuesday\, November 3rd \n				1:00 pm ET to 2:00 pm ET \n			\n		\n				\n							\n					\n				\n						\n				Online Webinar \n																	Link Available for Attendees \n																			\n		\n	\n\n\n\n\n\n\n\nEvent Details: Everything inside this box will not show on the front end but will be used by the event template
URL:https://recademy.com/event/whats-working-in-oud-treatment-system-transformation-roi-of-lai-moud-for-health-systems-payers-communities/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://recademy.com/wp-content/uploads/2026/02/AdobeStock_296468884-scaled.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260224T130000
DTEND;TZID=America/New_York:20260224T140000
DTSTAMP:20260608T195345Z
CREATED:20260123T033200Z
LAST-MODIFIED:20260608T195345Z
UID:4897-1771938000-1771941600@recademy.com
SUMMARY:Designing the OUD Cascade of Care: What Works in Real-World Provider Settings
DESCRIPTION:Despite major advances in medications for opioid use disorder (MOUD)\, most individuals with OUD continue to fall out of care at critical transition points—emergency departments\, hospital discharge\, residential treatment\, and jail reentry.  \n\n\n\n \n\n\n\nThis session will highlight how high-performing provider organizations are strengthening each stage of the OUD Cascade of Care—from screening and initiation to stabilization\, retention\, and recovery—using practical\, evidence-based strategies that can be implemented today.  \n\n\n\n\n\n\n\n\nSpeakers\n\n\n\n\n\n	\n			\n		\n						\n							\n						\n						\n\n\n\n\n\n\n\n\n\nHeidi Ginter \n\n\n\n\n\n\n\nAcadia Healthcare \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nHeidi B. Ginter\, MD\, FASAM is the Medical Director of Addiction Medicine at Acadia Healthcare. Board-certified in both family and addiction medicine\, Dr. Ginter brings nearly two decades of experience treating substance use disorders. \n\n\n\nDr. Ginter earned her bachelor’s degree from Yale University\, her MD from the University of Maryland School of Medicine\, and completed her family medicine residency at the University of Massachusetts Chan School of Medicine. Early in her career at a community health center in Worcester\, MA\, she practiced the full spectrum of family medicine\, including obstetrics\, and was introduced to addiction medicine through managing methadone for incarcerated pregnant people with opioid use disorder. This experience in the early 2000’s deeply impacted the trajectory of Dr. Ginter’s career as she became passionate about advocating for better care for these incredibly vulnerable and marginalized individuals. \n\n\n\nAs Dr. Ginter began trying to improve access to respectful\, quality care\, a key initiative in her early career was launching the first buprenorphine treatment program at her community health center. Dr. Ginter has since provided medical leadership across a range of settings\, including opioid treatment programs (OTPs)\, inpatient withdrawal management\, residential addiction treatment\, outpatient office-based programs\, and hospital addiction consult services. Her work has focused on building bridges between different levels of care\, ensuring continuity and accessibility for patients. \n\n\n\nIn addition to her clinical leadership\, Dr. Ginter is a nationally recognized speaker who advocates for reducing stigma and increasing public understanding of substance use disorders and their treatment. She envisions a future where everyone seeking treatment can access high quality\, affordable\, evidence-based care and whatever other resources they need to achieve recovery on their own terms\, whenever and wherever they are ready. \n\n\n\n\n		\n	\n		\n	\n	\n		\n		\n			Heidi  Ginter\n			\n				Medical Director\, 	\n				Acadia Healthcare 	\n			\n										\n					Read More				\n					\n	\n\n\n\n\n\n\n	\n			\n		\n						\n							\n						\n						\n\n\n\n\n\n\n\n\n\n\n\nStuart Buttlaire \n\n\n\n\n\n\n\nVice President Of Clinical Excellence & Leadership \n\n\n\n\n\n\n\ninfo@openminds.com \n\n\n\n717-334-1329 \n\n\n\nGettysburg\, Pennsylvania \n\n\n\n\n\n\n\n\n\nExpertise\n\n\n\n\nStrategic planning for mental health and substance use delivery systems \n\n\n\nIntegrated behavioral health system design \n\n\n\nBehavioral health financing and policy reform and state and federal legislative and regulatory strategy \n\n\n\nMeasurement-based care and clinical performance management \n\n\n\nBehavioral health policy authorship and thought leadership \n\n\n\n\nHighlights\n\n\n\n\nRegional Director of Behavioral Health and Addiction Medicine\, Kaiser Permanente \n\n\n\nBoard President\, Institute for Behavioral Health Improvement \n\n\n\nBoard Member\, NAMI California \n\n\n\nAdvisor on Medicaid and Medicare behavioral health programs \n\n\n\n\n\n\n\n\nBiography\n\n\n\n\n\n\n\nStuart Buttlaire brings over 35 years of executive\, clinical\, and policy experience to OPEN MINDS. Dr. Buttlaire has experience in both the public and private sectors of healthcare providing leadership and direction in healthcare delivery. His career has focused on advancing integrated behavioral health and addiction medicine through strategic innovation\, system redesign\, quality improvement\, and sustainable policy reform.Previously\, Dr. Buttlaire was the Regional Director of Behavioral Health and Addiction Medicine for Kaiser Permanente. In this role\, Dr. oversaw a $200 million portfolio serving 4.6 million members across 23 emergency departments and 33 medical centers. He led development and operations across inpatient\, ambulatory\, emergency\, call center\, and contracted community services\, supporting more than 2\,500 mental health and substance use disorder providers. His leadership resulted in significant system transformation grounded in person-centered\, measurement-based\, and integrated care models. Dr. Buttlaire was also the lead Mental Health Representative for State Program Initiatives\, including Medicaid (Medi-Cal) and Medicare. He pioneered the design and implementation of two psychiatric inpatient units\, including a nationally recognized medical/psychiatric unit for individuals with complex co-morbidities. Additional innovations include integrated urgent services for youth and adults\, intensive outpatient programs\, multi-family group treatments for severe psychiatric conditions\, and a mobile app for eating disorders that earned Kaiser’s Innovation Award.Dr. Buttlaire is a widely respected advisor on behavioral health policy\, legislation\, and regulatory strategy. He has worked closely with state and federal agencies on issues of parity enforcement\, financing reform\, Medicaid redesign\, and systems integration. He currently serves as Board President of the Institute for Behavioral Health Improvement\, is a Board Member of NAMI California\, and sits on the California Hospital Association Behavioral Health Advisory Board. He previously chaired the Behavioral Health Section of the American Hospital Association and was appointed to the AHA Regional Policy Board for the Western U.S.As a frequent speaker and author\, Dr. Buttlaire has published articles and research papers on behavioral health integration\, suicide prevention\, financing\, and policy reform. His work continues to shape strategic direction for public and private behavioral health systems across the country.Dr. Buttlaire holds a Ph.D. in Clinical Psychology from the California Institute of Integral Studies\, an MBA with a concentration in Health Care Management and Finance from UC Irvine’s Paul Merage School of Business\, a Master’s in Counseling Psychology from Humboldt State\, and a B.A. in Psychology and Political Science from the University of Colorado. \n\n\n\n\n		\n	\n		\n	\n	\n		\n		\n			Stuart Buttlaire\n			\n				Vice President Of Clinical Excellence & Leadership\, 	\n				OPEN MINDS 	\n			\n										\n					Read More				\n					\n	\n\n\n\n\n\n\nWhat You’ll Learn:\n\n\n\n\n\n\n\n\nWhere the most common drop-offs occur across the OUD Cascade of Care\n\n\n\nEvidence-based strategies to improve engagement\, initiation\, and retention\n\n\n\nHow workflow redesign\, staffing models\, and peer support improve continuity\n\n\n\nThe role of long-acting injectables (LAIs) in strengthening early and mid-stage retention\n\n\n\nHow to map your organization’s cascade and identify high-impact improvement opportunities\n\n\n\n\n\n\n\n	\n		\n							\n					\n				\n						\n				Tuesday\, November 3rd \n				1:00 pm ET to 2:00 pm ET \n			\n		\n				\n							\n					\n				\n						\n				Online Webinar \n																	Link Available for Attendees \n																			\n		\n	\n\n\n\n\n\n\n\nEvent Details: Everything inside this box will not show on the front end but will be used by the event template
URL:https://recademy.com/event/designing-the-oud-cascade-of-care-what-works-in-real-world-provider-settings/
ATTACH;FMTTYPE=image/jpeg:https://recademy.com/wp-content/uploads/2026/01/Recademy_Webinar1_HeroImage.jpg
END:VEVENT
END:VCALENDAR